Search results (142)
« Back to NewsType 1 diabetes research centre at University of Oxford marks its first year
13 Nov, 2026
Scientists and clinicians are making progress towards a better future for people affected by type 1 diabetes, by exploring how to delay the onset of the condition, develop new treatments, and improve everyday care.
Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation
12 Nov, 2026
Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.
Oxford-led research identifies a new therapeutic strategy to reverse established atrial fibrosis in atrial fibrillation
30 Oct, 2026
Researchers at the University of Oxford have identified a promising new RNA-based therapeutic approach that can reverse established atrial fibrosis. Atrial fibrosis is a major contributor to atrial fibrillation, the most common sustained cardiac arrhythmia worldwide.
Gene editing points to new treatment approach for inherited blood disorder
20 Oct, 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have used genome editing to reactivate an embryonic globin gene, offering a potential new strategy for treating severe α-thalassaemia.
Everyday DNA damage reveals a hidden weakness in some cancers
28 Sep, 2026
Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.
How body fat is stored across organs may reveal hidden health risks, study suggests
7 Sep, 2026
University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.
New personalised therapy targets chronic blood cancer
2 Jul, 2026
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.
Professor Jan Rehwinkel receives funding to tackle viral threats
25 Jun, 2026
A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
AI tool reveals hidden organ damage caused by high blood pressure
22 Jun, 2026
Researchers at the University of Oxford have developed an artificial intelligence (AI) tool that may help doctors better understand how high blood pressure damages different organs in different people - potentially paving the way for more personalised treatment in future.
New studies shed light on how best to guide heart artery procedures
19 Jun, 2026
Three clinical trials have shed new light on which approaches are most useful when treating narrowed heart arteries. They challenge the current guidance on how to insert stents.
Heart scan and blood test improve risk prediction for inherited heart condition, major study finds
11 May, 2026
A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) – a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.
Naveed Akbar awarded International Cardiovascular Research Partnership funding
7 May, 2026
Leading mid-career scientists from the UK, France, Germany, and the Netherlands have received almost €6 million from a pioneering partnership between the British Heart Foundation (BHF), the Dutch Heart Foundation (DHF), the German Centre for Cardiovascular Research (DZHK) and the Lefoulon Delalande Foundation (LDF), to support vital international research collaborations work over four years.
Research uncovers new mechanism controlling inflammation in immune cells
29 Apr, 2026
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 Apr, 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
New AI tool can predict heart failure at least five years before it develops
8 Apr, 2026
Programme uses data from routine CT scans to help doctors identify high-risk patients earlier than ever before
Heavier drinking linked to higher levels of harmful “hidden” fat, study finds
25 Mar, 2026
A study of more than 5,700 adults suggests that higher alcohol consumption is associated with increased levels of visceral fat - the type of fat stored deep inside the abdomen and linked to poorer health outcomes.
Study identifies immune–metabolic pathway as potential target in diabetic heart disease
19 Mar, 2026
Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.
New study reveals how blood cell production responds to parasite infection
11 Mar, 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.